Finance

Lists
SER:NYSEAMERICAN
Serina Therapeutics Inc
$1.85
-0.54%
(-0.0100) 1D
Nov 2, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SER...
Mkt. cap
46.99M
Avg. vol.
76.16K
Volume
80.00
52-wk high
$4.99
52-wk low
$1.22
EPS
-$1.88
Beta
1.31
Shares outstanding
25.40M
No. of employees
16
Mkt. cap
46.99M
Avg. vol.
76.16K
Volume
80.00
52-wk high
$4.99
52-wk low
$1.22
EPS
-$1.88
Beta
1.31
Shares outstanding
25.40M
No. of employees
16
News stories
From web sources and news partners
About Serina Therapeutics Inc
CEO-
Employees16
Founded2006
HeadquartersHuntsville, Alabama, United States
SectorBiotechnology
Websiteserinatx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
3.65M
3.40M
3.20M
3.82M
Cost of revenue
3.65M
3.40M
3.20M
3.82M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.74M
2.81M
3.08M
2.97M
Operating expense
2.74M
2.81M
3.08M
2.97M
Total operating expenses
6.39M
6.21M
6.28M
6.78M
Operating income
-6.39M
-6.21M
-6.28M
-6.78M
Other non operating income
1.80M
3.09M
1.19M
631.00K
EBT including unusual items
-4.60M
-3.32M
-6.89M
-6.36M
EBT excluding unusual items
-4.60M
-3.32M
-5.28M
-6.36M
Income tax expense
-
18.00K
7.00K
-
Effective tax rate
-
-0.54%
-0.10%
-
Other operating expenses
-
-
-
-
Net income
-4.58M
-3.34M
-6.90M
-6.36M
Net profit margin
-
-
-
-
Earnings per share
-0.51
-0.31
-0.53
-0.52
Interest and investment income
-
-
-
-
Interest expense
-6.00K
-198.00K
-189.00K
-203.00K
Net interest expenses
-6.00K
-198.00K
-189.00K
-203.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.38M
-6.18M
-6.26M
-6.77M
Gain or loss from assets sale
-
257.00K
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps